Levi & Korsinsky notifies investors that it has commenced an investigation into Treace Medical Concepts, Inc. (NASDAQ: TMCI) concerning potential violations of the federal securities laws.
On May 7, 2024 Treace Medical Concepts Inc. announced Q1 2024 financial results that met revenue estimates but lowered its guidance for the full year 2024 blaming it on “competitive pressure in its business.” Following this news, Treace’s stock price fell by $6.95 per share, or approximately 62% on the same day.
If you suffered a loss on your Treace Medical Concepts, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





